Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A practical heparin reduction algorithm: execution and operational characteristics.

H E Branson, D van Stralen, J Schottinger

    Journal of Clinical Pathology
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial).

    Journal of cancer research and clinical oncology·2023
    Same author

    Universal preprocedural SARS-CoV-2 testing protocol within a large healthcare system.

    The British journal of surgery·2021
    Same author

    Top-down assessment of the Asian carbon budget since the mid 1990s.

    Nature communications·2016
    Same author

    Optimizing rectal cancer management: analysis of current evidence.

    Diseases of the colon and rectum·2014
    Same author

    Hypogonadism in a patient with mild hereditary haemochromatosis.

    The Netherlands journal of medicine·2012
    Same author

    Development and characterization of an adriamycin-resistant sw480 human colon adenocarcinoma cell-line.

    International journal of oncology·2011
    Same journal

    Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

    Journal of clinical pathology·2026
    Same journal

    MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

    Journal of clinical pathology·2026
    Same journal

    Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

    Journal of clinical pathology·2026
    Same journal

    MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

    Journal of clinical pathology·2026
    Same journal

    Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

    Journal of clinical pathology·2026
    Same journal

    Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

    Journal of clinical pathology·2026
    See all related articles

    A new heparin reduction algorithm (HRA) pilot study shows it can safely monitor combined heparin and coumarin therapy. This approach precisely titrates heparin withdrawal, maintaining therapeutic anticoagulation levels.

    Area of Science:

    • Pharmacology
    • Clinical Chemistry
    • Medical Informatics

    Background:

    • Simultaneous anticoagulation with heparin and coumarins presents challenges in monitoring and dose titration.
    • Existing methods like activated partial thromboplastin time after heparin removal (aPTT/HR) have limitations in assessing combined drug effects.
    • A novel heparin reduction algorithm (HRA) was developed to address these monitoring complexities.

    Observation:

    • The HRA was successfully implemented in a pilot study involving six patients over 24-hour intervals.
    • The algorithm provided data on the individual and collective pharmacological effects of co-administered heparin and coumarins.
    • Laboratory data management facilitated precise titration of heparin withdrawal based on daily coumarin effect fluctuations.

    Findings:

    Related Experiment Videos

    • The HRA demonstrated feasibility and safety in a pilot study setting.
    • It enabled continuous maintenance of the activated partial thromboplastin time within the desired therapeutic interval.
    • The algorithm accurately reflected the evolving anticoagulant effect of coumarin, allowing for precise heparin management.

    Implications:

    • The HRA offers a novel approach for managing patients on combined anticoagulant therapy.
    • It allows for precise titration of heparin, improving patient safety and therapeutic efficacy.
    • This method has the potential to optimize anticoagulation management in complex clinical scenarios.